Inhibitory Effect of Resveratrol on Lipopolysaccharide-induced p21 (WAF1/CIP1) and Bax Expression in Astroglioma C6 Cells

C6 신경교세포에서 lipopolysaccharide에 의한 p21 (WAF1/CIP1) 및 Bax의 발현증가에 미치는 resveratrol의 영향

  • Kim, Young-Ae (Institute of Natural Medicine, Toyama Medical and Pharmaceutical University) ;
  • Lim, Sun-Young (Division of Ocean Science, Korea Maritime University) ;
  • Rhee, Sook-Hee (Department of Food Science and Nutrition, Pusan National University) ;
  • Choi, Yung-Hyun (Department of Biochemistry, Dongeui University College of Oriental Medicine and Biomedical Research Center of Oriental Medicine)
  • 김영애 (일본 부산의과약과대학 화한약연구소) ;
  • 임선영 (한국해양대학교 해양과학기술대학 해양과학부) ;
  • 이숙희 (부산대학교 생활환경대학 식품영양학과) ;
  • 최영현 (동의대학교 한의과대학 생화학교실 및 한방바이오연구센터)
  • Published : 2005.02.25

Abstract

Resveratrol, a phytoalexin found at high levels in grapes and in grape products such as red wine, has been reported to possess a wide range of biological and pharmacological activities including anti-oxident, anti-inflammatory, anti-mutagenic, and anti-carcinogenic effects, but its molecular mechanism is poorly understood. In this study, we examined the effects of resveratrol on lipopolysaccharide (LPS)-induced growth inhibitory activity and cell growth-regulatory gene products in astroglioma C6 cells to elucidate its possible mechanism for anti-cytotoxicity. It is shown that LPS induced time-dependent growth inhibition and morphological changes of C6 cells, which were recovered by pre-treatment with resveratrol. The anti-proliferative effect of LPS was associated with the induction of tumor suppressor p53 and cyclin-dependent kinase (Cdk) inhibitor p21 (WAF1/CIP1) expression assessed by RT-PCR and Western blot analysis in time-dependent manner in C6 cells. In addition, the pro-apoptotic Bax expression was also up-regulated in LPS-treated C6 cells without alteration of anti-apoptotic Bcl-2 and Bcl-XL expression. However, resveratrol significantly inhibited LPS-induced p53, p21 and Bax levels, suggesting that the modulation of p53, p21 and Bax levels could be one of the possible pathways by which resveratrol functions as anti-cytotoxic agent.

Keywords

References

  1. Hansson, E., Astroglia from defined brain regions as studied with primary cultures. Prog Neurobiol, 30, 369-397, 1988.
  2. Harder, D.R., Zhang, C., Gebremedhin, D., Astrocytes function in matching blood flow to metabolic activity. News Physiol Sci. 17, 27-31, 2002.
  3. Mazzanti, M., Sui, J.Y., Haydon, P.G., Glutamate on demand: astrocytes as a ready source. Neuroscientist. 7, 396-405, 2001.
  4. Lue, L.F., Walker, D.G., Rogers, J., Modeling microglial activation in Alzheimer's disease with human postmortem microglial cultures. Neurobiol Aging. 22, 945-956, 2001.
  5. Streit, W.J., Graeber, M.B., Kreutzberg, G.W., Functional plasticity of microglia: a review. Glia. 1, 301-307, 1988.
  6. Chao, C.C., Hu, S., Molitor, T.W., Shaskan, E.G., Peterson, P.K., Activated microglia mediate neuronal cell injury via a nitric oxide mechanism. J Immunol. 149, 2736-2741, 1992.
  7. Mrak, R.E., Sheng, J.G., Griffin, W.S., Glial cytokines in Alzheimer's disease: review and pathogenic implications, Hum Pathol. 26, 816-823, 1995.
  8. Stewart, R.R., Membrane properties of microglial cells isolated from the leech central nervous system. Proc R Soc Lond B Biol Sci. 255, 201-208, 1994.
  9. Meda, L., Cassatella, M.A., Szendrei, G.I., Otvos, L. Jr, Baron, P., Villalba, M., Ferrari, D., Rossi, F., Activation of microglial cells by $\beta$-amyloid protein and interferon-$\gamma$. Nature. 374, 647-650, 1995.
  10. El Khoury, J., Hickman, S.E., Thomas, C.A., Cao, L., Silverstein, S.C., Loike, J.D., Scavenger receptor-mediated adhesion of microglia to beta-amyloid fibrils. Nature. 382, 716-719, 1996.
  11. Bhat, K.P.L., Kosmeder, J.W. 2nd, Pezzuto, J.M., Biological effects of resveratrol. Antioxid Redox Signal. 3, 1041-1064, 2001.
  12. Ahmad, N., Adhami, V.M., Afaq, F., Feyes, D.K., Mukhtar, H., Resveratrol causes WAF-1/p21-mediated G(1)-phase arrest of cell cycle and induction of apoptosis in human epidermoid carcinoma A431 cells. Clin Cancer Res. 7, 1466-1473, 2001.
  13. Huang, C., Ma, W.Y., Goranson, A., Dong, Z., Resveratrol suppresses cell transformation and induces apoptosis through a p53-dependent pathway. Carcinogenesis. 20, 237-242, 1999.
  14. Kim, Y.A., Lee, W.H., Choi, T.H., Rhee, S.H., Park, K.Y., Choi, Y.H., Involvement of p21, pRB, Bax and NF-$\kappa$B in induction of growth arrest and apoptosis by resveratrol in human lung carcinoma A549 cells. Int J Oncol. 23, 1143-1149, 2003.
  15. She, Q.B., Bode, A.M., Ma, W.Y., Chen, N.Y., Dong, Z., Resveratrol-induced activation of p53 and apoptosis is mediated by extracellular-signal-regulated protein kinases and p38 kinase. Cancer Res. 61, 1604-1610, 2001.
  16. Surh, Y.J., Hurh, Y.J., Kang, J.Y., Lee, E., Kong, G., Lee, S.J., Resveratrol, an antioxidant present in red wine, induces apoptosis in human promyelocytic leukemia (HL-60) cells. Cancer Lett. 140, 1-10, 1999.
  17. Jang, J.H., Surh, Y.J., Protective effects of resveratrol on hydrogen peroxide-induced apoptosis in rat pheochromocytoma (PC12) cells. Mutat Res. 496, 181-190, 2001. https://doi.org/10.1016/S1383-5718(01)00233-9
  18. Jang, J.H., Surh, Y.J., Protective effect of resveratrol on $\beta$-amyloid-induced oxidative PC12 cell death. Free Radic Biol Med. 34, 1100-1110, 2003.
  19. Choi, Y.H., Kong, K.R., Kim, Y.A., Jung, K.O., Kil, J.H., Rhee, R.H., Park, K.Y., Induction of Bax and activation of caspases during $\beta$-sitosterol-mediated apoptosis in human colon cancer cells. Int J Oncol. 23, 1657-1661, 2003.
  20. Choi, Y.H., Lee, S.J., Nguyen, P., Jang, J.S., Lee, J., Wu, M.L., Takano, E., Maki, M., Henkart, P.A., Trepel, J.B., Regulation of cyclin D1 by calpain protease. J Biol Chem. 272, 28479-28484, 1997.
  21. Bhavnani, B.R., Cecutti, A., Gerulath, A., Woolever, A.C., Berco, M., Comparison of the antioxidant effects of equine estrogens, red wine components, vitamin E, and probucol on low-density lipoprotein oxidation in postmenopausal women. Menopause. 8, 408-419, 2001.
  22. Wang, Z., Huang, Y., Zou, J., Cao. K., Xu, Y., Wu, J.M., Effects of red wine and wine polyphenol resveratrol on platelet aggregation in vivo and in vitro. Int J Mol Med. 9, 77-79, 2002.
  23. Zoberi, I., Bradbury, C.M., Curry, H.A., Bisht, K.S., Goswami, P.C., Roti, J.L., Gius, D., Radiosensitizing and anti-proliferative effects of resveratrol in two human cervical tumor cell lines. Cancer Lett. 175, 165-173, 2002.
  24. Lin, J.K., Tsai, S.H., Chemoprevention of cancer and cardiovascular disease by resveratrol. Proc Natl Sci Counc Repub China B. 23, 99-106, 1999.
  25. Surh, Y.J., Chun, K.S., Cha, H.H., Han, S.S., Keum, Y.S., Park, K.K., Lee, S.S., Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: down-regulation of COX-2 and iNOS through suppression of NF-$\kappa$B activation. Mutat Res. 480-481, 243-268, 2001.
  26. Draczynska-Lusiak, B., Chen, Y.M., Sun, A.Y., Oxidized lipoproteins activate NF-$\kappa$B binding activity and apoptosis in PC12 cells. Neuroreport. 9, 527-532, 1998.
  27. Chan, M.M., Antimicrobial effect of resveratrol on dermatophytes and bacterial pathogens of the skin. Biochem Pharmacol. 63, 99-104, 2002.
  28. Docherty, J.J., Fu, M.M., Stiffler, B.S., Limperos, R.J., Pokabla, C.M., DeLucia, A.L., Resveratrol inhibition of herpes simplex virus replication. Antiviral Res. 43, 145-155, 1999.
  29. Zou, J., Huang, Y., Chen, Q., Wei, E., Cao, K., Wu, J.M., Effects of resveratrol on oxidative modification of human low density lipoprotein. Chin Med J(Engl). 113, 99-102, 2000..
  30. El-Deiry, W.S., Tokino, T., Velculesco. V.E., Levy, D.B., Parsons, R., Trent, J.M., Lin, D., Mercer, E.W., Kinzler, K.W., Vogelstain, B., WAF1, a potential mediator of p53 tumor suppression. Cell. 75, 817-825, 1993.
  31. Miyashita, T., Reed, J.C., Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell. 80, 293-299, 1995.
  32. Morgan, D.O., Principles of CDK regulation. Nature. 374, 131-134, 1995.
  33. Sherr, C.J., The Pezcoller lecture: cancer cell cycles revisited. Cancer Res. 60, 3689-3695, 2000.
  34. Hockenbery, D.M., Oltvai, Z.M., Yin, X.M., Milliman, C.L., Korsmeyer, S.J., Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell. 75, 241-251, 1993.
  35. Reddy, B.S., Wang, C.X., Samaha, H., Lubet, R., Steele, V.E., Kelloff, G.J., Rao, C.V., Chemoprevention of colon carcinogenesis by dietary perillyl alcohol. Cancer Res. 57, 420-425, 1997.
  36. Chiarugi, V., Magnelli, L., Basi, G., Apoptosis and the cell cycle. Cell Mol Biol Res. 40, 603-612, 1994.
  37. Lowe, S.W., Ruley, H.E., Jacks, T., Housman, D.E., p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell. 74, 957-967, 1993.